| 2.34 0.18 (8.33%) | 11-19 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 2.94 | 1-year : | 3.38 |
| Resists | First : | 2.51 | Second : | 2.89 |
| Pivot price | 2.19 |
|||
| Supports | First : | 1.89 | Second : | 1.58 |
| MAs | MA(5) : | 2.13 |
MA(20) : | 2.24  |
| MA(100) : | 2.76 |
MA(250) : | 3.12 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 54.2 |
D(3) : | 39.2 |
| RSI | RSI(14): 53 |
|||
| 52-week | High : | 7.65 | Low : | 1.29 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ SNYR ] has closed below upper band by 13.8%. Bollinger Bands are 53% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.38 - 2.38 | 2.38 - 2.39 |
| Low: | 2.1 - 2.11 | 2.11 - 2.12 |
| Close: | 2.32 - 2.34 | 2.34 - 2.35 |
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; anti-aging skincare products, such as serums and creams for exfoliating, skin repair, and rehydration, as well as hand soaps and hand sanitizers under the Hand MD brand name. The company sells its products through retailers and television advertising campaigns, as well as skincare products through online. The company was formerly known as Synergy Strips Corp. and changed its name to Synergy CHC Corp. in August 2015. Synergy CHC Corp. was incorporated in 2010 and is based in Westbrook, Maine.
Tue, 18 Nov 2025
Synergy CHC (NASDAQ: SNYR) Roth Capital Updates Report as - openPR.com
Tue, 18 Nov 2025
Synergy CHC (NASDAQ: SNYR) Roth Capital Updates Report as FOCUSfactor® Beverage Expands Across U.S. - FinancialContent
Tue, 18 Nov 2025
Oracle (NYSE: ORCL) elevates Magouyrk, Sicilia to CEOs and reaffirms guidance - Stock Titan
Fri, 14 Nov 2025
Roth Capital Maintains Synergy CHC (SNYR) Buy Recommendation - Nasdaq
Thu, 13 Nov 2025
Synergy CHC Corp. Sustains Profitability with Revenue Growth - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Distribution
|
|
| Shares Out | 11 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 56.4 (%) |
| Held by Institutions | 14.5 (%) |
| Shares Short | 52 (K) |
| Shares Short P.Month | 105 (K) |
| EPS | 0.37 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.74 |
| Profit Margin | 7.4 % |
| Operating Margin | 15.9 % |
| Return on Assets (ttm) | 23.6 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 12.3 % |
| Gross Profit (p.s.) | 2.19 |
| Sales Per Share | 3.09 |
| EBITDA (p.s.) | 0.56 |
| Qtrly Earnings Growth | -90 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | 6.15 |
| PEG Ratio | 0 |
| Price to Book value | -3.21 |
| Price to Sales | 0.75 |
| Price to Cash Flow | -3.95 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|